W. Jones

The effects of an immunomodulatory LFA3-IgG1 fusion protein on nonhuman primates.

P. Hochman, C. A. Williams, W. Meier, 1994, Therapeutic immunology.

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

R. Herndon, R. Rudick, J. Simon, 1998, Neurology.

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

A. Whitty, S. Goelz, M. Karpusas, 1998, Pharmaceutical research.

Pharmacokinetics and Pharmacodynamics of Interferon Beta-la (IFNβ-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration

M. Rogge, W. Jones, A. Mcallister, 1997 .

Comparative Pharmacokinetics and Pharmacodynamics of Two Recomhinant Human Interferon Beta-la (IFNβ-la) Products Administered Intramuscularly in Healthy Male and Female Volunteers

S. Goelz, P. Rioux, M. Rogge, 1997, Pharmaceutical Research.

Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β)

Adrian Whitty, Werner Meier, A. Whitty, 1998, Pharmaceutical Research.

Use of a standardized MxA protein measurement-based assay for validation of assays for the assessment of neutralizing antibodies against interferon-β.

J. Files, M. Wadhwa, P. Dilger, 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Immunomodulation by LFA3TIP, an LFA-3/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers.

M. Rogge, P. Hochman, A. Gill, 1995, Therapeutic immunology.

Results of an Ongoing, Open-Label, Safety-Extension Study of Interferon Beta-1a (Avonex) Treatment in Multiple Sclerosis

R. Herndon, E. Waubant, R. Rudick, 1999 .

Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administration

N. Simonian, M. Rogge, W. Jones, 1999, European journal of neurology.

Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta‐1a after intramuscular and subcutaneous administration

A. Munafo, N. Simonian, I. Trinchard-Lugan, 1999, European journal of neurology.